News

EEMGS 2025
Tulya Kavaklioglu

Toxys CEO Giel Hendriks becomes EEMGS Vice President

[vc_row][vc_column][vc_column_text]Toxys CEO Giel Hendriks was announced as the new Vice President of the European Environmental Mutagenesis and Genomics Society (EEMGS) during the recent annual meeting of the society in Bratislava. Giel will fulfill this role for the next 2 years. As Toxys team, we are...

New publication PFAS NAMs
Tulya Kavaklioglu

Advancing Chemical Safety Testing Through NAMs!

[vc_row][vc_column][vc_column_text]We recently published an article entitled “Toxicological mode-of-action and developmental toxicity of different carbon chain length PFAS” in Toxicology Letters together with Honeywell. We utilized two of our advanced assays, ToxProfiler and ReproTracker, to assess the toxicological mode-of-action and developmental toxicity of different PFAS with varying...

ReproTracker 2.0 in hood
Tulya Kavaklioglu

Toxys Awarded £1M for phase 2 of CrossDART CRACK IT Challenge

To address the need for reliable cell based in vitro assays that predict the teratogenicity of new drug candidates in both human and other animal species, Toxys have participated in CrossDART CRACK IT Challenge, developing and characterizing muti-species assays. After successfully completing phase 1 of...

10th anniversary Toxys
Tulya Kavaklioglu

Toxys 2024 wrapped

[vc_row][vc_column][vc_column_text]2024 has been a year for exciting developments at Toxys. From ToxTracker OECD ring trial validation publication to launching ReproTracker 2.0 and MutaTracker, we are proud to have contributed to the shift towards utilizing New Approach Methodologies in toxicology. Let’s look back at some of...

ToxProfiler 384-well plate
Tulya Kavaklioglu

New publication: In vitro safety assessment of 100 chemicals with ToxProfiler

[vc_row][vc_column][vc_column_text]Toxys scientists recently published an article in Toxicology entitled “ToxProfiler: A novel human-based reporter assay for in vitro chemical safety assessment”. In this article, ToxProfiler is presented as a robust platform that not only provides accurate toxicity profiles of chemicals but also reveals their toxicological mode-of-action (MoA)....

10th anniversary Toxys
Tulya Kavaklioglu

Toxys celebrates 10th anniversary

[vc_row][vc_column][vc_column_text]2024 marks a significant chapter in Toxys history. We are 10 great years into our journey with many accomplishments, growth, dedication to scientific excellence and innovation, as well as fun and teamwork. Join us as we visit some of the significant moments from Toxys history.[/vc_column_text][/vc_column][/vc_row][vc_row...

in vitro assay
Tulya Kavaklioglu

Press Release: Toxys launches MutaTracker

[vc_row][vc_column][vc_empty_space height="50px"][vc_column_text] PRESS RELEASE Toxys launches MutaTracker®, an all-in-one mammalian cell-based mutagenicity and genotoxicity assay Toxys announces the release of MutaTracker®, an innovative new approach method that integrates error-corrected sequencing into the ToxTracker® genotoxicity assay Oegstgeest, The Netherlands. September 3rd, 2024 – Mutagentech and Toxys have collaborated on creating...

ReproTracker 2.0
Tulya Kavaklioglu

ReproTracker 2.0: Pioneering Animal-Free Developmental Toxicity Testing with Enhanced Throughput and Efficiency

[vc_row][vc_column][vc_column_text]27th of August 2024 - Today, Toxys announces the higher throughput format of the ReproTracker assay for animal-free developmental toxicity predictions. ReproTracker 2.0 represents a novel advancement in the field of developmental toxicity testing that combines higher throughput, reduced compound requirement, and faster results, all...

Water quality monitoring - ToxTracker
Tulya Kavaklioglu

ToxTracker included in KWR’s water quality assessment

[vc_row][vc_column][vc_column_text]The Dutch Water Research Institute KWR is dedicated to ensuring that the surface water quality in Europe improves, or at least not deteriorates. Considering that the water quality in the Netherlands is the worst of all EU member states (only 1% of Dutch waters are...